Wenjie Xu
Sales & Marketing at HUA MEDICINE (SHANGHAI) LTD.
Network origin in Wenjie Xu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Goizueta Business School-Emory
33
| College/University | Other Consumer Services | 33 |
China Pharmaceutical University
26
| College/University | Other Consumer Services | 26 |
| Public Company | Pharmaceuticals: Major | 19 | |
Astrazeneca China Ltd.
1
| Extinct | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wenjie Xu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DELTA AIR LINES, INC. | Airlines | Corporate Officer/Principal Consultant / Advisor | |
Voya Investment Management LLC
 Voya Investment Management LLC Investment ManagersFinance Voya Investment Management LLC (Voya IM) is a SEC-registered investment advisor headquartered in Atlanta, Georgia. The firm was founded in 1997 and formerly known as ING Investment Management LLC. They are a wholly owned subsidiary of VIM Holdings LLC, which is ultimately owned by Voya Financial, Inc. (NYSE: VOYA), formerly known as ING U.S. Inc. Voya IM primarily provides portfolio management services to affiliated and unaffiliated insurance companies utilizing a variety of investment styles. The firm also advises other insurance-related entities (e.g., reinsurance companies) as well as various types of institutional investors, such as pension plans, with respect to certain investment strategies. | Investment Managers | Portfolio Manager-Fixed Income Analyst-Fixed Income | |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Blackstone Liquid Credit Strategies LLC
 Blackstone Liquid Credit Strategies LLC Investment ManagersFinance Blackstone Liquid Credit Strategies LLC (BLCS) is a SEC-registered investment adviser and hedge fund manager headquartered in New York City. The firm was founded in 2007 and is a subsidiary of Blackstone Alternative Credit Advisors LP, which is ultimately held by Blackstone, Inc. (NYSE: BX). The firm was formerly known as GSO / Blackstone Debt Funds Management LLC and changed their name to Blackstone Liquid Credit Strategies LLC in 2020. BLCS serves as investment manager for (i) pooled investment vehicles operating as private investment funds and (ii) registered investment companies. | Investment Managers | Investment Committee Member | |
| SINOPHARM GROUP CO. LTD. | Medical Distributors | Director/Board Member President | |
| DTXS SILK ROAD INVESTMENT HOLDINGS COMPANY LIMITED | Engineering & Construction | Director/Board Member Corporate Secretary | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Investment Banks/Brokers | Corporate Officer/Principal | |
Cerberus Capital Management LP
 Cerberus Capital Management LP Investment ManagersFinance Cerberus Capital Management LP (Cerberus) is a private equity firm founded in 1992 by Stephen A. Feinberg and William L. Richter. It is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
China National Pharmaceutical Group Co., Ltd.
 China National Pharmaceutical Group Co., Ltd. BiotechnologyHealth Technology China National Pharmaceutical Group Co., Ltd. engages in the distribution, retail, scientific research and manufacture of healthcare products. The company is headquartered in Beijing, China. | Biotechnology | Corporate Officer/Principal Chairman | |
| Shanghai Jiao Tong University | College/University | Doctorate Degree Undergraduate Degree | |
| China Europe International Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Jilin University | College/University | Graduate Degree Undergraduate Degree | |
| The Hong Kong Polytechnic University | College/University | Graduate Degree Undergraduate Degree | |
Tricor Services Ltd.
 Tricor Services Ltd. Miscellaneous Commercial ServicesCommercial Services Tricor Services Ltd. provides accounting and consulting services. The company is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hong Kong Institute of Certified Public Accountants
 Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The Hong Kong Institute of Chartered Secretaries
 The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MICROPORT SCIENTIFIC CORPORATION | Medical Specialties | Corporate Secretary Corporate Secretary | |
| Roche (China) Co. Ltd. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
Verizon Ventures LLC
 Verizon Ventures LLC Investment ManagersFinance Verizon Ventures LLC (Verizon Ventures) is a venture capital subsidiary of Verizon Communications, Inc founded in 1990. The firm is headquartered in Basking Ridge, New Jersey. | Investment Managers | Private Equity Investor | |
| MOOD MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
Blackstone Credit /Private Equity/
 Blackstone Credit /Private Equity/ Investment ManagersFinance Blackstone Credit /Private Equity/ (Blackstone Credit) is a private equity subsidiary of Blackstone Alternative Credit Advisors LP founded in 2005. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| NANJING HICIN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Coland Pharmaceutical Co., Ltd.
 Coland Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Coland Pharmaceutical is a specialty pharmaceutical company focusing on marketing branded products and developing solid pipelines through collaboration with leading institutes. Its main interests are in the dedicated therapeutic areas Hepatitis, Immunology, Oncology, and other niche areas. Coland was started its sales operation in 2005. Daiding (Adefovir), a first-to-market generic that treats HBV was launched in 2005. With effective promotion, and brand building, Daiding achieved great success and gained the leading position in China. Its goal is to become a leading specialty pharmaceutical company in China with strong sales and marketing capabilities and solid product pipelines. The company was founded in 2003 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| COLAND HOLDINGS LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
SeaTec Consulting, Inc.
 SeaTec Consulting, Inc. Engineering & ConstructionIndustrial Services SeaTec Consulting, Inc. offers engineering and management consulting services. Its services include system engineering, business plan analysis, product development, program/business recovery, rapid prototyping, leadership/project MGT, value analysis and new business incubation services. The company was founded by Don Ferrel in 2000 and is headquartered in Bellevue, WA. | Engineering & Construction | Chairman Director/Board Member Corporate Officer/Principal | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CANSINO BIOLOGICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Doctorate Degree | |
| College of Pharmacy | College/University | Doctorate Degree | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Director/Board Member | |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Hua Medicine Technology (Hong Kong) Ltd. | Director/Board Member Director/Board Member Director/Board Member | ||
Banbury Private Capital LLC
 Banbury Private Capital LLC Investment ManagersFinance Banbury Private Capital LLC (BPC) is a private equity firm founded in 2020 by Braden T French and Langdon R Holzman. The firm is headquartered in Charlotte, North Carolina. | Investment Managers | Private Equity Investor Founder Private Equity Investor | |
| Guangdong Fullteam Chemicals Ltd. | Director/Board Member Director/Board Member | ||
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Chief Executive Officer Director/Board Member | |
| Guangdong Fuvo Industrial Co. Ltd. | Director/Board Member Director/Board Member | ||
| BRII BIOSCIENCES LIMITED | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Guangdong Sanvo Chemical Industry Technology Ltd.
 Guangdong Sanvo Chemical Industry Technology Ltd. Industrial SpecialtiesProcess Industries Part of SANVO Fine Chemicals Group Ltd., Guangdong Sanvo Chemical Industry Technology Ltd. manufactures architectural coating, wood coating, adhesives, spray wax, aerosol spray paint and sealant. The company is based in Zhongshan, China. | Industrial Specialties | Director/Board Member Director/Board Member | |
| Zhongshan Minhe Chemical Industry Technology Ltd. | Director/Board Member Director/Board Member | ||
| SANVO FINE CHEMICALS GROUP LIMITED | Industrial Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 111, INC. | Medical Distributors | Chief Executive Officer Director/Board Member | |
| Guangdon Shunde Sanvo Chemical Industry Technology Ltd. | Director/Board Member Director/Board Member | ||
| PHARMARON BEIJING CO., LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| China | 24 |
| United States | 17 |
| Hong Kong | 7 |
| Cayman Islands | 5 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 15 |
| Finance | 11 |
| Commercial Services | 8 |
| Consumer Services | 7 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 260 |
| Corporate Officer/Principal | 114 |
| Independent Dir/Board Member | 91 |
| Undergraduate Degree | 76 |
| Chairman | 47 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Yiu Wa Tsui | 46 |
| William Keller | 26 |
| Yong Liu | 26 |
| Lian Yong Chen | 24 |
| Wing Yan Yuen | 24 |
| Klaas Baks | 20 |
| Teh Ming Kwauk | 17 |
| Wing Sze Chan | 15 |
| Bin Zhou | 15 |
| Li Chen | 14 |
| Bing Qiang Chen | 14 |
| Yiu Leung Cheung | 12 |
| Jun Ling Liu | 11 |
| Wai Ming Loke | 11 |
- Stock Market
- Insiders
- Wenjie Xu
- Company connections
